Cedara Receives 2004 Fastest Growing Company of the Year Award from Frost and Sullivan FLORIDA, Nov. 10 /PRNewswire-FirstCall/ -- Cedara Software Corp. (NASDAQ:CDSW/TSX:CDE) a leading independent developer of medical software technologies for the global healthcare market, announced that Frost and Sullivan, America's foremost market research and consulting firm, has voted Cedara the recipient of its 2004 Fastest Growing Company of the Year Award. Frost and Sullivan formally presented the prestigious award to Cedara last night, at its 2004 Global Excellence in the Healthcare and Life Sciences Awards Banquet in Florida. Frost and Sullivan is a leading market consulting and research organization that monitors new technologies, tracks changes in distribution channels, forecasts market trends, and performs strategic analysis of competitors in the healthcare industry. Each year Frost and Sullivan recognizes outstanding industry achievements by presenting Frost & Sullivan Awards to top companies in regional and global markets. Its industry experts recognize the diligence and innovation required to implement a successful business plan and excel in the increasingly competitive global marketplace. "Cedara is honored to be the recipient of the highly esteemed Frost and Sullivan Fastest Growing Company of the Year Award, and to be recognized by an industry analyst of such exceptional caliber," said Abe Schwartz, Cedara President and CEO. "We have been following Cedara for many years and have been quite excited by their recent performance within the healthcare industry. They have grown from being a small niche competitor to one that offers a breadth of valuable medical software solutions to a diverse group of global healthcare clients. Their focus on cutting edge technologies in conjunction with flexible solutions has allowed them to make tremendous strides within the industry," says Monali Patel, Frost and Sullivan Research Manager, Medical Imaging. "Having our business model validated by a top industry analyst is a powerful endorsement of how successful Cedara is with its strategy of offering diversified, end-to-end products and services," said Jacques Cornet, Cedara Vice President of Marketing and Operations. About Cedara Software: Cedara Software Corp. is a leading independent provider of medical technologies for many of the world's leading medical device and healthcare information technology companies. Cedara software is deployed in hospitals and clinics worldwide - approximately 28,000 medical imaging systems and 6,400 Picture Archiving and Communications System (PACS) workstations have been licensed to date. Cedara is enabling the future of the healthcare industry with new innovative approaches to workflow, data and image management, integration, the web, software components and professional services. The Company's medical imaging solutions are used in all aspects of clinical workflow including the capture of patient digital images; the sharing and archiving of images; sophisticated tools to analyze and manipulate images; and even the use of imaging in surgery. Cedara is unique in that it has expertise and technologies that span all the major digital imaging modalities including angiography, computed tomography (CT), echo-cardiology, digital X-ray, fluoroscopy, mammography, magnetic resonance imaging (MRI), nuclear medicine, positron emission tomography (PET) and ultrasound. Certain statements contained in this news release are forward-looking within the meaning of securities laws and are based on current expectations that are subject to a number of assumptions, uncertainties and risks, and there are actual results may differ materially from what is currently expected. These assumptions, uncertainties and risks include, but are not limited to: the management of the growth of the Company, dependence on key personnel of the Company, competitive pressures (including price competition), changes in market activity, risks associated with international operations, the development of new products and services, the enhancement of existing products and services, the introduction of competing products having technological and/or other advantages, the dependence on key customers, regulatory changes to the health care industry, seasonality, economic and political conditions and adequate protection of the proprietary interests of the Company. Further information about these risks and uncertainties can be found in the continuous disclosure documents filed from time to time by Cedara with the securities regulatory authorities, which documents are available at http://www.sedar.com/. All trademarks appearing in this release are the property of Cedara Software Corp. DATASOURCE: Cedara Software Corp. CONTACT: For more information about Cedara and its products and services, visit the Cedara website at http://www.cedara.com/ or contact: Michelle Pommells, Cedara Software Corp., (905) 672-2100 ext. 2356, Email: .; For investor-related inquiries, contact: Brian Pedlar, Chief Financial Officer, (905) 672-2100 ext. 2015, Email: ; To request a free copy of this organization's annual report, please go to http://www.newswire.ca/ and click on reports@cnw.

Copyright